New genomic technique reveals obesity gene variants
Key points
- Obesity is highly heritable, but so far genetic association studies have only explained a small fraction of this heritability.
- Frazer said, "We sequenced two intervals encoding the enzymes FAAH and MGLL which modulate the levels of endocannabinoids present in the brain and peripheral tissues that are involved in the regulation of energy balance and appetite.
- In these two genes, the researchers were able to identify four regions associated with BMI: the FAAH promoter, MGLL promoter, MGLL intron 2, and an enhancer in the MGLL intron 3.
- Further testing of one of these regions revealed rare variants that were associated with increased levels of endocannabinoids in the plasma, which is consistent with previous findings.
Obesity is highly heritable, but so far genetic association studies have only explained a small fraction of this heritability. Now, in a study published in BioMed Central's open access journal Genome Biology, researchers have identified DNA variants in two nervous system genes that are associated with an excessively high BMI.
Kelly Frazer and colleagues from UC San Diego, Scripps Translational Science Institute and Sanofi-Aventis used a new approach that is likely to become popular in searching for hidden heritability: the resequencing of a candidate area of the genome in a large number of individuals followed by screening for genetic markers within this region that are associated with the disease or condition in question. Frazer said, "We sequenced two intervals encoding the enzymes FAAH and MGLL which modulate the levels of endocannabinoids present in the brain and peripheral tissues that are involved in the regulation of energy balance and appetite. The level of these endocannabinoids is high in obese patients, and thus these two enzymes provide strong candidates to examine for a genetic association with BMI".
In these two genes, the researchers were able to identify four regions associated with BMI: the FAAH promoter, MGLL promoter, MGLL intron 2, and an enhancer in the MGLL intron 3.
Further testing of one of these regions revealed rare variants that were associated with increased levels of endocannabinoids in the plasma, which is consistent with previous findings. According to Frazer, "This is one of the first studies to use the new sequencing technologies to link rare and low frequency variants to a complex trait such as obesity and will be of particular interest to understand more comprehensively the role of inheritance in obesity, a rapidly rising serious health issue across the world".
###
Notes to Editors
1. Population sequencing of two endocannabinoid metabolic genes identifies rare and common regulatory variants associated with extreme obesity and metabolite level
Olivier Harismendy, Vikas Bansal, Gaurav Bhatia, Masakazu Nakano, Michael Scott, Xiaoyun C Wang, Colette Dib, Edouard Turlotte, Jack C Sipe, Sarah S Murray, Jean-Francois Deleuze, Vineet Bafna, Eric J Topol and Kelly A Frazer
Genome Biology (in press)
During embargo, article available here: http://www.biomedcentral.com/imedia/5722664624366101_article.pdf?random=645184
After the embargo, article available at the journal website: http://genomebiology.com/
Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.
Article citation and URL available on request at [email protected] on the day of publication.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Public Health →What's your genetic destiny? More than half of parents want to know disease risks
Would you want to know if you or your children had risk of hereditary cancer, a genetic risk for cardiovascular disease or carried the gene associated with developing Alzheimer's disease - even if they were risks that…
10 March 2015